| Block 1: Adrenergics 1: Drugs |
18 |
block 1
|
2005-01-30 |
| Block 1: Adrenergics 2: Agonists |
16 |
block 1
|
2005-01-30 |
| Block 1: Adrenergics 3: Antagonists |
11 |
block 1
|
2005-01-30 |
| Block 1: Adrenergics 4: details |
13 |
block 1
|
2005-01-30 |
| Block 1: Adrenergics 5: Rx those adernergics! |
21 |
block 1
|
2005-01-30 |
| Block 1: Anesthetics- General |
62 |
block 1
|
2005-01-30 |
| Block 1: Anesthetics- Local |
30 |
block 1
|
2005-01-29 |
| Block 1: Autonomics- Introduction |
19 |
block 1
|
2005-01-30 |
| Block 1: Chemical Warfare |
13 |
block 1
|
2005-01-31 |
| Block 1: Cholinergics 1: drugs |
8 |
block 1
|
2005-01-31 |
| Block 1: Cholinergics 2: Muscarinic Agonists |
14 |
block 1
|
2005-01-31 |
| Block 1: Cholinergics 3: Muscarinic Antagonists |
21 |
block 1
|
2005-01-31 |
| Block 1: Cholinergics 4: Nicotinic agonists and antagonists |
35 |
block 1
|
2005-01-31 |
| Block 1: pharmicogenetics |
33 |
block 1
|
2005-01-29 |
| Block 1: Pharmicokinetics |
13 |
block 1
|
2005-01-30 |
| Block 1: Toxicology |
29 |
block 1
|
2005-01-29 |
| Block 2: Alcohol/Alcoholism |
81 |
block 2
|
2005-02-13 |
| Block 2: anti-depressants: choice of AD and tx of Bipolar Ds |
30 |
block 2
|
2005-02-20 |
| Block 2: anti-depressants: classify the drug |
29 |
block 2
|
2005-02-13 |
| Block 2: anti-depressants: mechanisms of action |
22 |
block 2
|
2005-02-13 |
| Block 2: anti-depressants: side effects and overdose |
34 |
block 2
|
2005-02-13 |
| Block 2: Antipsychotic Drugs |
60 |
block 2
|
2005-02-16 |
| Block 2: Antipsychotic drugs: overview |
10 |
block 2
|
2005-02-24 |
| Block 2: Antiseizure: Absence, General, Other |
27 |
block 2
|
2005-02-23 |
| Block 2: Antiseizure: General |
36 |
block 2
|
2005-02-23 |
| Block 2: Antiseizure: Partial and Gen. TC |
40 |
block 2
|
2005-02-23 |
| Block 2: Antiseizure:Managment of Epilepsy |
6 |
block 2
|
2005-02-23 |
| Block 2: asthma |
43 |
block 2
|
2005-02-20 |
| Block 2: asthma drugs |
20 |
block 2
|
2005-02-20 |
| Block 2: Autocoids |
67 |
block 2
|
2005-02-21 |
| Block 2: Autocoids: Histamine |
51 |
block 2
|
2005-02-21 |
| Block 2: Autocoids: the end |
35 |
block 2
|
2005-02-21 |
| Block 2: CNS neurotransmitters |
60 |
block 2
|
2005-02-07 |
| Block 2: Drugs of abuse: marijuana and hallucinogens |
57 |
block 2
|
2005-02-20 |
| Block 2: drugs of abuse: stimulants |
68 |
block 2
|
2005-02-20 |
| Block 2: GI drugs: Antimicrobial,spasmodic,emetic, and prokinetic |
31 |
block 2
|
2005-02-21 |
| Block 2: GI drugs: MPA, H2RA, PPI, PGs |
30 |
block 2
|
2005-02-21 |
| Block 2: GI Drugs:Antidiarrheal, laxatives |
16 |
block 2
|
2005-02-22 |
| Block 2: Gout |
40 |
block 2
|
2005-02-19 |
| Block 2: Immuno:Monoclonal, Other |
43 |
block 2
|
2005-02-22 |
| Block 2: Immunosuppressive drugs: Calci, Cytokine |
38 |
block 2
|
2005-02-22 |
| Block 2: Inflammatory Disorders |
66 |
block 2
|
2005-02-19 |
| Block 2: Metabolism, Pharmacokinetics, and Toxicity of NSAIDs |
35 |
block 2
|
2005-02-21 |
| Block 2: Neurodegenerative Disorders |
65 |
block 2
|
2005-02-10 |
| Block 2: Sedative-Hypnotics |
92 |
block 2
|
2005-02-13 |
| Block 2: Treatment of Pain: Opiates |
90 |
block 2
|
2005-02-16 |
| Block 3: Adrenal Steroids |
42 |
block 3
|
2005-03-31 |
| Block 3: Adrogens/Estrogens |
56 |
block 3
|
2005-03-31 |
| Block 3: Anti-anginal drugs |
24 |
block 3
|
2005-03-30 |
| Block 3: Antiarrhythmic drugs |
29 |
block 3
|
2005-03-31 |
